REFERENCES
- Baum, C. F. (2009). An Introduction to Stata Programming. College Station, TX: Stata Press.
- Benjamini, Y., Hochberg, Y. (1995). Controlling the false discovery rate: A practical and powerful approach to multiple testing. Journal of the Royal Statistical Society B 57:289–300.
- Chou, T.-C. (2006). Theoretical basis, experimental design, and computerized simulation of synergism and antagonism in drug combination studies. Pharmacological Reviews 58:621–681.
- Coles, S. (2001) An Introduction to Statistical Modeling of Extreme Values. London: Springer-Verlag.
- Diaz, F. J., McDonald, P. R., Roy, A., Taylor, B., Price, A., Hall, J., Blagg, B. S. J., and Chaguturu, R. (2013). Compound ranking based on a new mathematical measure of effectiveness using time course data from cell-based assays. Combinatorial Chemistry & High Throughput Screening 16:168–179.
- Goutelle, S., Maurin, M., Rougier, F., Barbaut, X., Bourguignon, L., Ducher, M., Maire, P. (2008). The Hill equation: A review of its capabilities in pharmacological modelling. Fundamental & Clinical Pharmacology 22:633–648.
- Krachmarov, C. P., Kayman, S. C., Honnen, W. J., Trochev, O., Pinter, A. (2001). V3-specific polyclonal antibodies affinity purified from sera of infected humans effectively neutralize primary isolates of human immunodeficiency virus type 1. AIDS Research and Human Retroviruses 17:1737–1748.
- Pinter, A., Honnen, W. J., He, Y., Gorny, M. K., Zolla-Pazner, S., Kayman, S. C. (2004). The V1/V2 domain of gp120 is a global regulator of the sensitivity of primary human immunodeficiency virus type 1 isolates to neutralization by antibodies commonly induced upon infection. Journal of Virology 78:5205–5215.
- Shao, J. (2003). Mathematical Statistics, 2nd ed. New York, NY: Springer.
- Wolfram Research, Inc. (2008). Mathematica, Version 7.0. Champaign, IL.